Theranostics Nanomaterials in Drug Delivery

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing. Prof. N.K. Jain is an internationally renowned academician and researcher and a senior professor in India who superannuated in June 2014 after rendering more than 40 years of dedicated and distinguished service as a teacher and 25 years as full professor. Prof. Jain is the author of two dozen celebrated books in pharmaceutical sciences in India and has contributed several chapters in national and international books. He has to his credit over 480 publications in reputed pharmaceutical Journals and has supervised 55 PhD and 141 M. Pharm. candidates. He has been a reviewer for several international and national research journals. Professor Jain’s current research interests include various aspects of controlled, novel and targeted drug delivery; nanotechnology and nanomedicine and he is globally known for his excellent research in the field of hydrotropic solubilization, resealed erythrocytes-based drug delivery and dendrimer drug delivery. Currently he is exploring the pharmaceutical potential of Carbon Nanotubes and Quantum Dots.

• 1. An Overview of Theranostic Nanomedicine2. Nano–bio interactions of nanomedicines3. Molecular and cellular targets for the development of target selective theranostics4. Multifunctional theranostic nanomaterials as MRI contrast agents and imaging5. Theranostics Nanoemulsions Mediated Drug Delivery6. Theranostics liposomes mediated drug delivery7. Theranostics Exosomes Mediated Drug Delivery8. Theranostics Polymeric Micelles Mediated Drug Delivery9. Theranostics PLGA nanoparticles mediated drug delivery10. Theranostics Chitosan Nanoparticles Mediated Drug Delivery11. Theranostics Dendrimer Mediated Drug Delivery12. Theranostics Quantum Dots Mediated Drug Delivery13. Theranostics Silica Nanoparticles Mediated Drug Delivery14. Theranostics Gold Nanoparticles Mediated Drug Delivery15. Theranostics Silver Nanoparticles Mediated Drug Delivery16. Theranostics Magnetic Nanoparticles Mediated Drug Delivery17. Multifunctional Theranostic Nanomedicine for Cancer Therapy18. Multifunctional Theranostic Nanomedicine for Infectious Diseases19. Theranostic Nanomaterials for Intervention of the Blood–brain Barrier20. siRNA and Aptamer Engineered Theranostic Systems in Drug Delivery21. Advances in theranostic nanocarriers for cancer immunotherapy22. Toxicity and Safety Aspects of Theranostic Drug Delivery23. Regulatory Pathways and Clinical Translation of Theranostic Drug Delivery24. Future of Theranostic Drug Delivery